• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导性多巴胺能神经元:帕金森病的新希望。

Induced dopaminergic neurons: A new promise for Parkinson's disease.

作者信息

Xu Zhimin, Chu Xingkun, Jiang Houbo, Schilling Haley, Chen Shengdi, Feng Jian

机构信息

Veterans Affairs Western New York Healthcare System, Buffalo, NY 14215, USA; Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, NY 14214, USA; Laboratory of Neurodegenerative Diseases, Institute of Health Science, Shanghai Institutes for Biological Sciences, Chinese Academy of Science and Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Laboratory of Neurodegenerative Diseases, Institute of Health Science, Shanghai Institutes for Biological Sciences, Chinese Academy of Science and Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

出版信息

Redox Biol. 2017 Apr;11:606-612. doi: 10.1016/j.redox.2017.01.009. Epub 2017 Jan 16.

DOI:10.1016/j.redox.2017.01.009
PMID:28110217
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5256671/
Abstract

Motor symptoms that define Parkinson's disease (PD) are caused by the selective loss of nigral dopaminergic (DA) neurons. Cell replacement therapy for PD has been focused on midbrain DA neurons derived from human fetal mesencephalic tissue, human embryonic stem cells (hESC) or human induced pluripotent stem cells (iPSC). Recent development in the direct conversion of human fibroblasts to induced dopaminergic (iDA) neurons offers new opportunities for transplantation study and disease modeling in PD. The iDA neurons are generated directly from human fibroblasts in a short period of time, bypassing lengthy differentiation process from human pluripotent stem cells and the concern for potentially tumorigenic mitotic cells. They exhibit functional dopaminergic neurotransmission and relieve locomotor symptoms in animal models of Parkinson's disease. In this review, we will discuss this recent development and its implications to Parkinson's disease research and therapy.

摘要

定义帕金森病(PD)的运动症状是由黑质多巴胺能(DA)神经元的选择性丧失引起的。PD的细胞替代疗法一直集中于源自人类胎儿中脑组织、人类胚胎干细胞(hESC)或人类诱导多能干细胞(iPSC)的中脑DA神经元。人类成纤维细胞直接转化为诱导多巴胺能(iDA)神经元的最新进展为PD的移植研究和疾病建模提供了新机会。iDA神经元在短时间内直接从人类成纤维细胞产生,绕过了从人类多能干细胞开始的漫长分化过程以及对潜在致瘤性有丝分裂细胞的担忧。它们在帕金森病动物模型中表现出功能性多巴胺能神经传递并缓解运动症状。在这篇综述中,我们将讨论这一最新进展及其对帕金森病研究和治疗的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aea7/5256671/20d01f4df430/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aea7/5256671/78a3f5bf614d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aea7/5256671/20d01f4df430/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aea7/5256671/78a3f5bf614d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aea7/5256671/20d01f4df430/gr1.jpg

相似文献

1
Induced dopaminergic neurons: A new promise for Parkinson's disease.诱导性多巴胺能神经元:帕金森病的新希望。
Redox Biol. 2017 Apr;11:606-612. doi: 10.1016/j.redox.2017.01.009. Epub 2017 Jan 16.
2
Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.基于人胚胎干细胞(hESC)、人诱导多能干细胞(hiPSC)和非人类灵长类动物 iPSC 来源的多巴胺能神经元的分化效率和安全性改进的帕金森病细胞治疗方案。
Stem Cells. 2013 Aug;31(8):1548-62. doi: 10.1002/stem.1415.
3
Redefining Parkinson's disease research using induced pluripotent stem cells.使用诱导多能干细胞重新定义帕金森病研究。
Curr Neurol Neurosci Rep. 2012 Aug;12(4):392-8. doi: 10.1007/s11910-012-0288-1.
4
Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.帕金森病多巴胺能细胞替代和再生策略的研究进展。
ACS Chem Neurosci. 2019 Feb 20;10(2):839-851. doi: 10.1021/acschemneuro.8b00389. Epub 2018 Oct 24.
5
Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease.人诱导多能干细胞衍生的中脑多巴胺能神经元在帕金森病灵长类动物模型脑内的存活。
J Parkinsons Dis. 2011;1(4):395-412. doi: 10.3233/JPD-2011-11070.
6
Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.人诱导多能干细胞衍生的神经元改善6-羟基多巴胺诱导的帕金森病大鼠模型中的运动不对称。
Cytotherapy. 2015 May;17(5):665-79. doi: 10.1016/j.jcyt.2015.02.001. Epub 2015 Mar 5.
7
Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease.人诱导多能干细胞衍生的中脑细胞球体在功能上整合到纹状体回路中,并在帕金森病小鼠模型中恢复运动功能。
Theranostics. 2023 Apr 29;13(8):2673-2692. doi: 10.7150/thno.80271. eCollection 2023.
8
Clinical translation of stem cell transplantation in Parkinson's disease.帕金森病中干细胞移植的临床转化。
J Intern Med. 2016 Jan;279(1):30-40. doi: 10.1111/joim.12415. Epub 2015 Aug 31.
9
Stem cell therapies for Parkinson's disease: are trials just around the corner?帕金森病的干细胞疗法:临床试验即将来临?
Regen Med. 2014;9(5):553-5. doi: 10.2217/rme.14.43.
10
Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.帕金森病发病机制对神经退行性疾病中细胞替代策略和药物发现的影响。
CNS Neurol Disord Drug Targets. 2012 Nov 1;11(7):907-20. doi: 10.2174/1871527311201070907.

引用本文的文献

1
Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy.诱导多能干细胞在类器官和细胞治疗中的应用前景
Int J Mol Sci. 2024 Feb 26;25(5):2680. doi: 10.3390/ijms25052680.
2
PTBP2 attenuation facilitates fibroblast to neuron conversion by promoting alternative splicing of neuronal genes.PTBP2 衰减通过促进神经元基因的可变剪接促进成纤维细胞向神经元的转化。
Stem Cell Reports. 2023 Nov 14;18(11):2268-2282. doi: 10.1016/j.stemcr.2023.09.012. Epub 2023 Oct 12.
3
Mitochondrial transport in symmetric and asymmetric axons with multiple branching junctions: a computational study.

本文引用的文献

1
Cycling through developmental decisions: how cell cycle dynamics control pluripotency, differentiation and reprogramming.循环经历发育决策:细胞周期动力学如何控制多能性、分化和重编程。
Development. 2016 Dec 1;143(23):4301-4311. doi: 10.1242/dev.142075.
2
Kinetic barriers in transdifferentiation.转分化中的动力学障碍。
Cell Cycle. 2016;15(8):1019-20. doi: 10.1080/15384101.2016.1151730. Epub 2016 Feb 22.
3
Conversion of adult human peripheral blood mononuclear cells into induced neural stem cell by using episomal vectors.
具有多个分支结的对称和非对称轴突中的线粒体运输:计算研究。
Comput Methods Biomech Biomed Engin. 2024 Jul;27(9):1071-1090. doi: 10.1080/10255842.2023.2226787. Epub 2023 Jul 10.
4
Efficient Generation of Dopaminergic Neurons from Mouse Ventral Midbrain Astrocytes.从小鼠腹侧中脑星形胶质细胞高效生成多巴胺能神经元。
Biomol Ther (Seoul). 2023 May 1;31(3):264-275. doi: 10.4062/biomolther.2022.140. Epub 2023 Jan 16.
5
The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.利用成纤维细胞作为研究神经紊乱中线粒体损伤的有价值策略。
Transl Neurodegener. 2022 Jul 4;11(1):36. doi: 10.1186/s40035-022-00308-y.
6
The Different Molecular Code in Generation of Dopaminergic Neurons from Astrocytes and Mesenchymal Stem Cells.星形胶质细胞和间充质干细胞生成多巴胺能神经元的不同分子密码。
Int J Mol Sci. 2021 Nov 9;22(22):12141. doi: 10.3390/ijms222212141.
7
Association between the DRD2 TaqIA gene polymorphism and Parkinson disease risk: an updated meta-analysis.DRD2 TaqIA基因多态性与帕金森病风险之间的关联:一项更新的荟萃分析。
Medicine (Baltimore). 2019 Sep;98(37):e17136. doi: 10.1097/MD.0000000000017136.
8
Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PD.人类神经元中的表观遗传学分析:帕金森病疾病建模的考量因素
Front Neurosci. 2019 Apr 5;13:276. doi: 10.3389/fnins.2019.00276. eCollection 2019.
9
Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease.用于模拟帕金森病中α-突触核蛋白传播的患者来源诱导多能干细胞和类器官
Front Cell Neurosci. 2018 Nov 9;12:413. doi: 10.3389/fncel.2018.00413. eCollection 2018.
10
Transdifferentiation: a new promise for neurodegenerative diseases.转分化:神经退行性疾病的新希望。
Cell Death Dis. 2018 Aug 6;9(8):830. doi: 10.1038/s41419-018-0891-4.
利用附加型载体将成人外周血单个核细胞转化为诱导神经干细胞。
Stem Cell Res. 2016 Mar;16(2):236-42. doi: 10.1016/j.scr.2016.01.016. Epub 2016 Jan 15.
4
Direct Reprogramming of Mouse Fibroblasts to Neural Stem Cells by Small Molecules.小分子介导的小鼠成纤维细胞直接重编程为神经干细胞
Stem Cells Int. 2016;2016:4304916. doi: 10.1155/2016/4304916. Epub 2015 Dec 16.
5
Modeling Neurological Disease by Rapid Conversion of Human Urine Cells into Functional Neurons.通过将人尿液细胞快速转化为功能性神经元来模拟神经疾病
Stem Cells Int. 2016;2016:2452985. doi: 10.1155/2016/2452985. Epub 2015 Dec 7.
6
Direct Lineage Reprogramming Reveals Disease-Specific Phenotypes of Motor Neurons from Human ALS Patients.直接谱系重编程揭示了人类肌萎缩侧索硬化症(ALS)患者运动神经元的疾病特异性表型。
Cell Rep. 2016 Jan 5;14(1):115-128. doi: 10.1016/j.celrep.2015.12.018. Epub 2015 Dec 24.
7
Reprogramming somatic cells to cells with neuronal characteristics by defined medium both in vitro and in vivo.通过特定培养基在体外和体内将体细胞重编程为具有神经元特征的细胞。
Cell Regen. 2015 Dec 30;4:12. doi: 10.1186/s13619-015-0027-6. eCollection 2015.
8
Induction of neural differentiation in rat C6 glioma cells with taxol.用紫杉醇诱导大鼠C6胶质瘤细胞的神经分化
Brain Behav. 2015 Oct 26;5(12):e00414. doi: 10.1002/brb3.414. eCollection 2015 Dec.
9
Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons.细胞周期和p53调控人类成纤维细胞向多巴胺能神经元的直接转化。
Nat Commun. 2015 Dec 7;6:10100. doi: 10.1038/ncomms10100.
10
Generation of functional human serotonergic neurons from fibroblasts.从成纤维细胞生成功能性人血清素能神经元。
Mol Psychiatry. 2016 Jan;21(1):49-61. doi: 10.1038/mp.2015.161. Epub 2015 Oct 27.